Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 6,191 | 8,949 | 5,663 | 2,759 | 2,082 |
| Cost of Goods | 3,155 | 5,187 | 3,371 | 1,356 | 1,225 |
| Gross Profit | 3,035 | 3,763 | 2,292 | 1,403 | 856 |
| Operating Expenses | 6,326 | 4,235 | 3,605 | 2,968 | 2,476 |
| Operating Income | -3,136 | -285 | -942 | -1,210 | -1,394 |
| Interest Expense | 177 | 742 | 733 | 671 | 588 |
| Other Income | 12 | -57 | 16 | -76 | -1 |
| Pre-tax Income | -3,301 | -1,084 | -1,660 | -1,957 | -1,984 |
| Net Income Continuous | -3,301 | -1,084 | -1,660 | -1,957 | -1,984 |
| Minority Interests | -83 | N/A | N/A | N/A | N/A |
| Net Income | $-3,218 | $-1,084 | $-1,660 | $-1,957 | $-1,984 |
| EPS Basic Total Ops | -0.31 | -0.22 | -0.33 | -0.42 | -0.42 |
| EPS Basic Continuous Ops | -0.32 | -0.22 | -0.33 | -0.39 | -0.40 |
| EPS Diluted Total Ops | -0.31 | -0.22 | -0.33 | -0.42 | -0.42 |
| EPS Diluted Continuous Ops | -0.32 | -0.22 | -0.33 | -0.39 | -0.40 |
| EBITDA(a) | $-2,865 | $18 | $-694 | $-1,038 | $-1,323 |